Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:53:46 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



Q:EVFM - EVOFEM BIOSCIENCES INC - https://www.evofem.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EVFM - Qnot subscribed0.01675+0.0025518.0555.97550.013  0.0185  0.0133.75  0.012215:58:42Apr 1815 min RT 2¢

Recent Trades - Last 10 of 55
Time ETExPriceChangeVolume
15:58:42Q0.016750.00255565
15:48:40Q0.01610.00191
15:46:43Q0.016460.0022619,992
15:45:30Q0.01610.00191
15:35:01Q0.0170.002825,000
15:27:02Q0.015550.001352
15:22:04Q0.015650.0014520,000
15:20:59Q0.01540.00123
14:41:31Q0.01780.003613,000
13:48:22Q0.01780.00361,900

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 08:36U:EVFMNews ReleaseEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO
2024-03-27 08:36U:EVFMNews ReleaseEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023
2024-03-20 08:54U:EVFMNews ReleaseEvofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal
2024-03-07 07:54U:EVFMNews ReleaseFor Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
2024-02-01 08:00U:EVFMNews ReleaseEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
2024-01-08 08:30U:EVFMNews ReleaseWashington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game
2023-12-12 08:30U:EVFMNews ReleaseAditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi ‚ ®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
2023-11-14 06:56U:EVFMNews ReleaseEvofem Biosciences Announces Financial Results for the Third Quarter of 2023
2023-10-24 07:36U:EVFMNews ReleaseEvofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
2023-10-13 11:36U:EVFMNews ReleaseEvofem to Participate in the Virtual Investor Ask the CEO Conference
2023-09-27 08:47U:EVFMNews ReleaseEvofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi ‚ ® Until Evofem's Phexxi Patents Expire
2023-09-11 08:00U:EVFMNews ReleaseEvofem Biosciences Successfully Amends S.P.A. with Institutional Investor
2023-08-22 16:01U:EVFMNews ReleaseEvofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange
2023-08-14 17:00U:EVFMNews ReleaseEvofem Biosciences Announces Financial Results for the Second Quarter of 2023
2023-07-06 08:42U:EVFMNews ReleaseEvofem to Participate in the Virtual Investor Summer Spotlight Series
2023-06-16 16:01U:EVFMNews ReleaseEvofem Biosciences Announces Financial Results for the First Quarter of 2023
2023-06-01 08:36U:EVFMNews ReleaseEvofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
2023-05-17 16:50U:EVFMNews ReleaseEvofem Biosciences Announces 1-for-125 Reverse Stock Split